Epidemiology of Haemophilus influenzae bacteremia: A multi-national population-based assessment

Journal of Infection

Volumn 62, Issue 2, 2011, Pages 142-148

  Laupland, Kevin B ^a,b   Schønheyder, Henrik C ^c   Østergaard, Christian ^d   Knudsen, Jenny Dahl ^e   Valiquette, Louis ^f   Galbraith, John ^g   Kennedy, Karina J ^h   Gradel, Kim O ⁱ  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

^g ROYAL JUBILEE HOSPITAL   (Canada)

^h AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

ⁱ ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bloodstream infection; Incidence; Mortality; Risk factor; Vaccine

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTEREMIA; CANADA; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; COMORBIDITY; DENMARK; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE A; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS INFLUENZAE TYPE C; HAEMOPHILUS INFLUENZAE TYPE F; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION RATE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SEX RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BACTEREMIA; CANADA; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DENMARK; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; SEROTYPING;

EID: 79551575443     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.11.009     Document Type: Article

References (31)

1. Tsang R.S., Sill M.L., Skinner S.J., Law D.K., Zhou J., Wylie J. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis 2007, 44(12):1611-1614.
2. Dworkin M.S., Park L., Borchardt S.M. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis 2007, 44(6):810-816.
3. Degani N., Navarro C., Deeks S.L., Lovgren M. Invasive bacterial diseases in northern Canada. Emerg Infect Dis 2008, 14(1):34-40.
4. Bisgard K.M., Kao A., Leake J., Strebel P.M., Perkins B.A., Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998, 4(2):229-237.
5. Farley M.M., Stephens D.S., Brachman P.S., Harvey R.C., Smith J.D., Wenger J.D. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med 1992, 116(10):806-812.
6. Takala A.K., Eskola J., van Alphen L. Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med 1990, 150(12):2573-2576.
7. Peltola H., Aavitsland P., Hansen K.G., Jonsdottir K.E., Nokleby H., Romanus V. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis 1999, 179(1):223-229.
8. Campos J., Hernando M., Roman F., Perez-Vazquez M., Aracil B., Oteo J., et al. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol 2004, 42(2):524-529.
9. Kalies H., Siedler A., Grondahl B., Grote V., Milde-Busch A., von Kries R. Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era. BMC Infect Dis 2009, 9:45.
10. Bender J.M., Cox C.M., Mottice S., She R.C., Korgenski K., Daly J.A., et al. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis 2010, 50(7):e41-e46.
11. Shetty S., Cohen A.L., Edmond K., Ojo L., Loo J., O'Loughlin R., et al. a systematic review and critical evaluation of invasive Haemophilus influenzae type B disease burden studies in Asia from the last decade: lessons learned for invasive bacterial disease surveillance. Pediatr Infect Dis J 2010.
12. Adam H.J., Richardson S.E., Jamieson F.B., Rawte P., Low D.E., Fisman D.N. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010, 28(24):4073-4078.
13. Ladhani S., Slack M.P., Heath P.T., von Gottberg A., Chandra M., Ramsay M.E. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg Infect Dis 2010, 16(3):455-463.
14. Wenger J.D. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998, 17(Suppl. 9):S132-S136.
15. Kellner J.D., Church D.L., MacDonald J., Tyrrell G.J., Scheifele D. Progress in the prevention of pneumococcal infection. CMAJ 2005, 173(10):1149-1151.
16. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348(18):1737-1746.
17. Bajanca P., Canica M. Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989-2001). J Clin Microbiol 2004, 42(2):807-810.
18. Laupland K.B., Schonheyder H.C., Kennedy K.J., Lyytikainen O., Valiquette L., Galbraith J., et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Res Notes 2009, 2:146.
19. Sundararajan V., Quan H., Halfon P., Fushimi K., Luthi J.C., Burnand B., et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care 2007, 45(12):1210-1215.
20. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
21. CLSI Performance standards for antimicrobial susceptibility testing: twentieth informational supplement 2010, CLSI document M100-S20, Clinical and Laboratory Standards Institute, Wayne PA.
22. Schonheyder H.C., Sogaard M. Existing data sources for clinical epidemiology: the North Denmark bacteremia research Database. Clin Epidemiol 2010, 2:171-178.
23. Kennedy K.J., Roberts J.L., Collignon P.J. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Med J Aust 2008, 188(4):209-213.
24. Allard C., Carignan A., Bergevin M., Boulais I., Tremblay V., Robichaud P., et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008, 14(5):421-428.
25. Laupland K.B., Gregson D.B., Church D.L., Ross T., Pitout J.D. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008, 14(11):1041-1047.
26. Tsang R.S., Mubareka S., Sill M.L., Wylie J., Skinner S., Law D.K. Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era. J Clin Microbiol 2006, 44(4):1530-1535.
27. Vergison A., Tuerlinckx D., Verhaegen J., Malfroot A. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics 2006, 118(3):e801-e809.
28. Milde-Busch A., Kalies H., Ruckinger S., Siedler A., Rosenbauer J., von Kries R. Surveillance for rare infectious diseases: is one passive data source enough for Haemophilus influenzae?. Eur J Public Health 2008, 18(4):371-375.
29. Skogberg K., Lyytikainen O., Ruutu P., Ollgren J., Nuorti J.P. Increase in bloodstream infections in Finland, 1995-2002. Epidemiol Infect 2008, 136(1):108-114.
30. Rempel O.R., Laupland K.B. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect 2009, 137(12):1665-1673.
31. McVernon J., Trotter C.L., Slack M.P., Ramsay M.E. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 2004, 329(7467):655-658.